<i>FLT3-ITD</i> does not predict inferior prognosis in acute myeloid leukemia patients aged ≥60 years-Reference-Cited by-同舟云学术

FLT3-ITD does not predict inferior prognosis in acute myeloid leukemia patients aged ≥60 years

Published:2023-09-15 Issue:18 Volume:7 Page:5354-5358
ISSN:2473-9529
Container-title:Blood Advances
language:en
Short-container-title:

Author:

Shimony Shai¹²^ORCID,Fell Geoffrey³,Chen Evan C.¹,Tsai Harrison K.⁴,Wadleigh Martha¹,Winer Eric S.¹^ORCID,Garcia Jacqueline S.¹^ORCID,Luskin Marlise R.¹^ORCID,Stahl Maximilian¹,Neuberg Donna S.³,DeAngelo Daniel J.¹,Lindsley R. Coleman¹^ORCID,Stone Richard M.¹

Affiliation:

1. 1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA

2. 2Rabin Medical Center and Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

3. 3Department of Data Science, Dana-Farber Cancer Institute, Boston, MA

4. 4Department of Pathology, Boston Children’s Hospital, Boston, MA

Publisher

American Society of Hematology

Subject

Hematology

Link

https://ashpublications.org/bloodadvances/article-pdf/7/18/5354/2079935/blooda_adv-2023-009748-main.pdf

Reference22 articles.

1. Genomic classification and prognosis in acute myeloid leukemia;Papaemmanuil;N Engl J Med,2016

2. Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: a cancer and leukemia group B study;Whitman;Cancer Res,2001

3. Midostaurin plus chemotherapy for acute myeloid leukemia with a FLT3 mutation;Stone;N Engl J Med,2017

4. Gilteritinib or chemotherapy for relapsed or refractory FLT3-mutated AML;Perl;N Engl J Med,2019

5. Azacitidine and venetoclax in previously untreated acute myeloid leukemia;DiNardo;N Engl J Med,2020

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Innovations in conditioning and post-transplant maintenance in AML: genomically informed revelations on the graft-versus-leukemia effect;Frontiers in Immunology;2024-03-20

2. Acute Myeloid Leukemia Treatment in the Elderly: A Comprehensive Review of the Present and Future;Acta Haematologica;2023